October Term 2002 · Docket 01-188
Do uninsured patients pay higher drug prices?
Pharmaceutical Research and Manufacturers of America argues that cash-paying patients face higher costs. Kevin Concannon disputes this claim.
Showing 1–2 of 2 cases, newest official Court activity first.
October Term 2002 · Docket 01-188
Pharmaceutical Research and Manufacturers of America argues that cash-paying patients face higher costs. Kevin Concannon disputes this claim.
October Term 2002 · Docket 01-593
the sides that brought the case claim a foreign sovereign owns a subsidiary. the opposing sides say only direct shares count.